STANDARDIZATION OF HERBAL CAPSULE FORMULATIONS: A REVIEW

STANDARDIZATION OF HERBAL CAPSULE FORMULATIONS: A REVIEW

Mohd Adil Ansari, Rohit Kumar Bijauliya *, Pushpendra Kannojia and Pankaj Kumar Shankhdhar

BIU College of Pharmacy, Bareilly International University, Bareilly, Uttar Pradesh, India.

ABSTRACT: Herbal capsule formulations have gained significant attention due to their therapeutic potential, improved patient compliance, and growing global demand. However, their quality, safety, and efficacy are challenged by variability in raw materials, lack of uniform standards, and complex multi-component nature. This review highlights the comprehensive standardization of herbal capsule formulations, including raw material evaluation, physicochemical and phytochemical analysis, chromatographic fingerprinting, and capsule quality control parameters such as weight variation, disintegration, dissolution, and content uniformity. It also discusses microbiological safety, toxicological screening, and advanced techniques like DNA fingerprinting, marker-based standardization, and chemometric analysis. Regulatory frameworks from WHO, AYUSH, US FDA, and EMA are also summarized. Despite advancements, challenges such as lack of universal markers and variability in herbal sources persist. Integration of modern analytical tools with traditional knowledge is essential to ensure consistent, safe, and effective herbal capsule products for global acceptance.

Keywords: Herbal capsule standardization, Phytochemical analysis, Quality control parameters, Chromatographic fingerprinting, AYUSH and WHO guidelines

INTRODUCTION: Under AYUSH, India is a prominent center for ancient medical systems including Ayurveda, Unani, Siddha, and homoeopathy. With widespread adoption of goods including herbal medicines, nutraceuticals, cosmeceuticals, health supplements, extracts, and wellness services in both local and international markets, the AYUSH pharmaceutical sector has significant development potential. Throughout shelf life, storage, and usage, drug standardisation guarantees identification, quality, and purity. However, the lack of clear rules makes standardising Ayurvedic formulas difficult, requiring producers and regulatory organisations like PCIM&H to put in more effort ^{1, 2}.

The World Health Organization prioritises both qualitative and quantitative assessment, including fingerprint profiling and biomarker estimates. When known, active ingredients should be the focus of standardisation; otherwise, particular marker compounds should be used. Ensuring safety, purity, and efficacy is a crucial problem in the commercialisation of herbal medicine because of the variability in herbal raw materials caused by plant identification, seasonal, genetic, and environmental variables, as well as processing and storage conditions.

The American Herbal Products Association defines standardisation as the set of knowledge and control needed to create materials of uniform quality. It is accomplished by using stringent quality assurance procedures to cultivation, harvesting, processing, and manufacture in order to minimise inherent differences in herbal composition. These precautions guarantee safety, therapeutic dependability, and homogeneity from batch to batch ^{3, 4}. Standardisation is essential to preserving the identification, potency, and purity of goods in the herbal industries. Variability in active ingredients might result in variable therapeutic results if rigorous standardisation is not implemented. Therefore, in order to guarantee the repeatability and credibility of herbal formulations in both local and foreign markets, it is imperative to employ established analytical procedures and appropriate manufacturing standards. Although the Ayurvedic system has many advantages for humanity, it currently has trouble developing strong standardisation methods to guarantee dose accuracy, consistency, and efficacy ⁵. The World Health Organization claims that chromatographic techniques including GC, HPLC, and HPTLC are trustworthy instruments for standardising herbal medications by locating and measuring important biomarker chemicals ⁶. These sophisticated analytical methods allow for precise evaluation of intricate polyherbal mixtures. Despite this, it is challenging to identify a single active ingredient in herbal medications due to their multi-component structure. As a result, marker-based standardisation is frequently employed. Improving the therapeutic reliability and worldwide acceptance of Ayurvedic medicines requires strengthening scientific validation and implementing contemporary analytical techniques ^{7, 8, 9}.

In places like Africa, China, Egypt, India, and South America, medicinal plants have been utilised for ages as one of the first healthcare systems. Nearly 80% of the world's population is said to rely on herbal treatments for primary healthcare, especially when it comes to treating serious and chronic illnesses like malaria, cancer, and AIDS. Approximately 800 medicinal plants are used in many ancient systems, including as Ayurveda, Siddha, and Unani. With increasing global demand, herbal products are now formulated into modern dosage forms such as capsules, improving patient compliance, dosage accuracy, and stability while preserving their therapeutic potential ^{10, 11, 12}.

Capsules offer advantages such as:

• Accurate dosing
• Improved patient compliance
• Masking unpleasant taste and odor
• Enhanced stability

However, unlike synthetic drugs, herbal products contain complex mixtures of bioactive compounds, making standardization a challenging but critical process ¹³.

Need for Standardization: The increasing complexity and interconnection of contemporary systems, industries, and international markets necessitate standardisation since efficiency, safety, and quality control depend on uniformity and consistency. By establishing uniform rules, requirements, and processes, standardisation makes it possible for various businesses, goods, and services to collaborate easily, minimising misunderstandings and mistakes while enhancing communication and interoperability. Additionally, it makes mass manufacturing easier, reduces expenses, and guarantees that customers obtain dependable and secure goods ¹⁴. Standardisation fosters innovation in industries including technology, healthcare, manufacturing, and education by offering a solid foundation for the development and comparison of novel concepts. In the end, it promotes international commerce, strengthens stakeholder trust, and advances general economic and social progress.

TABLE 1: FACTORS AFFECTING STANDARDIZATION AND ITS SIGNIFICANCE IN HERBAL FORMULATIONS ^{15, 16}

Components of Standardization:

• Material Standardization Parameters
• Physicochemical Parameters

TABLE 2: RAW MATERIAL STANDARDIZATION PARAMETERS IN HERBAL FORMULATIONS ¹⁷

TABLE 3: PHYSICOCHEMICAL PARAMETERS IN HERBAL DRUG STANDARDIZATION ^{18, 19, 20}

Phytochemical Standardization:

1. Qualitative Analysis
2. Spectrophotometry
3. Chromatographic Techniques

TABLE 4: PRELIMINARY PHYTOCHEMICAL SCREENING PARAMETERS ^{21, 22, 23}

TABLE 5: QUANTITATIVE ANALYSIS BY SPECTROPHOTOMETRY IN HERBAL STANDARDIZATION ^{24, 25}

TABLE 6: CHROMATOGRAPHIC TECHNIQUES IN HERBAL FORMULATION STANDARDIZATION ^{25, 26}

These techniques help generate fingerprint profiles for consistency.

Standardization of Capsule Dosage Form:

1. Pre-formulation Studies
2. Capsule Evaluation Parameters
3. Stability Studies

TABLE 7: FLOW PROPERTIES OF POWDER ^{27, 28, 29}

TABLE 8: COMPATIBILITY STUDIES ^{30, 31}

TABLE 9: CAPSULE EVALUATION PARAMETERS ^{32, 33, 34, 35}

TABLE 10: STABILITY STUDIES OF FORMULATION ^{36, 37, 38}

Microbiological and Safety Evaluation ^{39, 40, 41}:

Microbial Load Testing:

Total Bacterial Count: Total bacterial count measures the number of viable bacteria present in a sample, usually expressed as colony-forming units (CFU) per gram or milliliter.

It is determined by plating diluted samples on nutrient agar and incubating them. This test ensures that microbial levels remain within acceptable pharmacopeial limits for safety.

Total Fungal Count: Total fungal count estimates the number of yeasts and molds in a sample, expressed as CFU per gram or milliliter. It is performed using suitable media like Sabouraud dextrose agar under controlled incubation. This test helps detect fungal contamination that may affect product stability, quality, and patient safety.

Detection of Pathogens (E. coli, Salmonella): This test identifies the presence of specific harmful microorganisms such as Escherichia coli and Salmonella species. Selective culture media and biochemical tests are used for detection. The absence of these pathogens is mandatory, as their presence can cause serious infections and indicates poor hygiene or contamination.

Toxicological Evaluation:

Heavy Metals (Lead, Arsenic, Mercury, Cadmium): Heavy metal testing determines the presence of toxic elements such as lead, arsenic, mercury, and cadmium in pharmaceutical products. These metals are detected using techniques like atomic absorption spectroscopy or ICP-MS. Their levels must remain within prescribed limits, as excessive exposure can cause serious health hazards and toxicity.

Pesticide Residues: Pesticide residue analysis detects traces of chemicals used during cultivation or storage of raw materials. Methods such as gas chromatography or liquid chromatography are employed for identification and quantification. Ensuring pesticide levels are within permissible limits is essential to avoid toxic effects and to maintain product safety and regulatory compliance.

Aflatoxins: Aflatoxins are toxic metabolites produced by fungi, especially Aspergillus species, contaminating raw materials. Their detection is carried out using methods like HPLC or ELISA. Even at low concentrations, aflatoxins can be carcinogenic, making it crucial to ensure their absence or presence within strict regulatory limits.

Advanced Standardization Techniques ^{42, 43}:

DNA Fingerprinting: DNA fingerprinting is a molecular technique used to confirm the identity of plant materials by analyzing their genetic profile. It helps distinguish authentic species from closely related or substituted ones. This method is highly reliable and is also used to detect adulteration, ensuring purity and authenticity of herbal raw materials.

Marker-Based Standardization: Marker-based standardization involves identifying and quantifying specific bioactive compounds (markers) present in herbal formulations. These markers may be responsible for therapeutic activity or serve as quality indicators. This approach ensures batch-to-batch consistency, maintains efficacy, and supports quality control of herbal medicines.

Chemometric Analysis: Chemometric analysis uses statistical and mathematical tools to interpret complex data obtained from herbal formulations. It helps analyze multiple chemical components simultaneously, identify patterns, and ensure quality consistency. This method is especially useful for standardizing complex herbal mixtures and detecting variations or adulteration.

Regulatory Guidelines: Various international bodies provide guidelines for herbal standardization ^{44, 45, 46, 47}:

WHO Guidelines for Herbal Medicines: The World Health Organization provides global guidelines for the quality, safety, and efficacy of herbal medicines. These include standards for raw material identification, good agricultural and collection practices (GACP), quality control, and stability testing to ensure safe and effective use worldwide.

AYUSH Guidelines (India): The Ministry of AYUSH regulates traditional medicine systems like Ayurveda, Yoga, Unani, Siddha, and Homeopathy. It sets standards for herbal drug manufacturing, quality control, labeling, and licensing under GMP guidelines to ensure safety, authenticity, and therapeutic effectiveness in India.

US FDA Botanical Drug Guidelines: The U.S. Food and Drug Administration provides specific guidance for botanical drug development, covering requirements for safety, efficacy, and quality. It includes recommendations on clinical trials, chemistry, manufacturing, and controls (CMC), ensuring botanical products meet the same standards as conventional drugs.

European Medicines Agency (EMA): The European Medicines Agency regulates herbal medicinal products in Europe through the Committee on Herbal Medicinal Products (HMPC). It provides monographs, guidelines for quality, safety, and efficacy, and supports traditional herbal medicine registration across European Union member states.

Challenges in Standardization:

• Complexity of multi-component systems
• Lack of universal markers
• Seasonal and geographical variation
• Limited scientific validation
• Inadequate regulatory harmonization ⁴⁸

Future Perspectives:

• Integration of modern analytical techniques
• Development of global standards
• Use of artificial intelligence in phytochemical profiling
• Increased clinical validation
• Stronger regulatory frameworks

CONCLUSIONS: Standardization of herbal capsule formulations is essential to ensure their safety, efficacy, and quality in both domestic and global markets. The complex nature of herbal drugs demands a multidisciplinary approach involving pharmacognostic, physicochemical, phytochemical, microbiological, and advanced analytical techniques. Quality control parameters and regulatory guidelines play a crucial role in achieving batch-to-batch consistency and therapeutic reliability. Although significant progress has been made, challenges such as variability in raw materials and lack of standardized markers still exist. The integration of modern technologies like DNA fingerprinting, chemometrics, and chromatographic fingerprinting with traditional knowledge systems can strengthen herbal drug development. A robust standardization framework will enhance global acceptance and clinical credibility of herbal capsule formulations.

ACKNOWLEDGEMENT: Nil

CONFLICT OF INTEREST: Nil

REFERENCES:

1. Ekka NR: Standardization strategies for herbal drugs-an overview research. J Pharm and Tech 2008; 1(4): 310-312.
2. Swapnil G and Patil: Standard tools for evaluation of herbal drugs: an overview. The Pharma Innovation Journal 2013; 2(9): 60.
3. Dixit VK and Yadav NP: Recent approaches in herbal drug standardization. Integr Biol 2008; 2(3): 195-203.
4. The Ayurvedic Pharmacopoeia of India. 1st ed. Part II, Vol. I. New Delhi: Government of India, Ministry of Health and Family Welfare 2007; 2(2.2.10): 140-141.
5. World Health Organization. Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminant and Residue. Geneva, Switzerland: WHO 2007.
6. Bijauliya RK, Alok S, Chanchal DK and Kumar M: A comprehensive review on standardization of herbal drugs. Int J Pharm Sci Res 2017; 8(9): 3663-77. doi: 10.13040/IJPSR.0975-8232.8(9).3663-77
7. Calixto JB and Barz J: Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Med Biol Res 2000; 33: 179-189.
8. Rajendran K, Senthilnathan M and Rajeswaran R: Morbidity profileof paediatric otorhinolaryngological disorders in a rural teaching hospital, Trichy, Tamil Nadu. Int J Otorhinolaryngol Head Neck Surg 2018; 4(5): 1247–51. Available from:https://www.ijorl.com/index.php/ijorl/article/view/1168
9. Marchisio P, Esposito S and Principi N: Treatment of acute pharyngitis in children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG). Ital J Pediatr 2024; 50: 123.
10. De Martin S, Caruso C and D’Angelo M: Open, randomised, controlled study to evaluate the role of a dietary supplement containing Pelargonium sidoides extract, honey, propolis, and zinc as adjuvant treatment in children with acute tonsillopharyngitis. Phytother Res 2024; 38(9): 4321–31.Available from: https://pubmed.ncbi.nlm.nih.gov/4015062
11. Yi-Zeng Liang, Peishan Xie and Kelvin Chan: Journal of Chromatography, December 2004: 812(1-2): 53-70.
12. Gupta MK and Sharma PK: Test Book of Pharmacognosy, Ayurvedic formulations, Pragati Prakashan Meerut Ist Edition 2007; 2.
13. Indian Pharmacopoeia 2010; 1: 198-201.
14. Organization, Geneva, Archana Gautam. Identification, evaluation and standardization of herbal drugs: A review, Der Pharmacia Lettre 2010; 2(6): 302-315.
15. Vaidya AD and Devasagayam TP: Current status of herbal drugs in India:an overview. Journal of Clinical Biochemistry and Nutrition 2007; 41(1): 1-11. https://doi.org/10.3164/jcbn.2007001
16. Makunga N, Philander L and Smith M: Current perspectives on an emerging formal natural products sector in South Africa. Journal of Ethnopharmacology 2008; 119(3): 365-75.https://doi.org/10.1016/j.jep.2008.07.020
17. Sagar BP, Zafar R, Panwar R, Kumar V and Mangla A: Herbal drugs standardization. The Indian Pharmacist 2005; 4(35): 19-22.
18. Emmons RA: Striving for the sacred: Personal goals, life meaning, and religion. Journal of Social 2005; 61(4): 731-45.https://doi.org/10.1111/j.1540-4560.2005.00429.x
19. Bandaranayake WM: Quality control, screening, toxicity, and regulation of herbal drugs. Modern phytomedicine: turning medicinal plants into drugs 2006; 25-57.https://doi.org/10.1002/9783527609987.ch2
20. Kumari R and Kotecha M: A review on the Standardization of herbal medicines. International Journal of Pharma Sciences and Research 2016; 7(2): 97-106.
21. Jordan SA, Cunningham DG and Marles RJ: Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicology and Applied Pharmacology 2010; 243(2): 198-216.https://doi.org/10.1016/j.taap.2009.12.005
22. Neethu S, Veena SK, Indulekha VC and Jollykutty Eapen KV: Radhakrishnan, Phytoconstituents assessment and development of standardization protocol for ‘Nayopayam Kwatha’, a polyherbal Ayurvedic formulation, Journal of Ayurveda and Integrative Medicine 2021; 12(3): 489-499.ISSN 0975- 9476.
23. Becker, Christina & Kamath and Madhusudhana: The challenges with the standardization of ayurvedic drugs. 2020; 8: 55-7.
24. Sasidharan S, Chen Y, Saravanan D, Sundram K and Latha LY: Extraction, isolation and characterization of bioactive compounds from plants' extracts. African Journal of Traditional, Complementary and Alternative Medicines. 2011; 8(1).https://doi.org/10.4314/ajtcam.v8i1.60483
25. Guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Geneva: World Health Organization 2007.
26. Parasuraman S, Thing GS and Dhanaraj SA: Polyherbal formulation: concept of Ayurveda. Pharmacogn Rev 2014; 8(16): 73–80.
27. Garg S and Bhutani KK: Chromatographic analysis of Kutajarista—an ayurvedic polyherbal formulation. Phytochem Anal 2008; 19(4): 323–8.
28. Nafiu M, Hamid A, Muritala H and Adeyemi S: Preparation, standardization, and quality control of medicinal plants in Africa. Medicinal Spices and Vegetables from Africa. 2017: 171-204.https://doi.org/10.1016/B978-0-12-809286-6.00007-8
29. Yang M, Sun J, Lu Z, Chen G, Guan S and Liu X: Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry. Journal of Chromatography A 2009; 1216(11): 2045-62.https://doi.org/10.1016/j.chroma.2008.08.097
30. Shi X, Zhang K, Xue N, Su L, Ma G, Qi J, Wu Y, Wang Q and Shi Q: Differentiation of genuine Inula Britannica L. and substitute specimens based on the determination of 15 components using LC–MS/MS and principal components analysis. Food Chem 2013; 141(4): 4019–25.
31. Song S, Ma J, Tian Q, Tong L and Guo X: Hexachlorobenzene in human milk collected from Beijing, China. Chemosphere 2013; 91(2): 145–9.
32. Ekor M: The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177. Available from:https://www.frontiersin.org/articles/10.3389/fphar.2013.00177/full
33. Ashiq S, Hussain M and Ahmad B: Natural occurrence of mycotoxins in medicinal plants: a review. Fungal Genetics and Biology 2014; 66: 1–10.
34. Wu HC, Wang Q and Yang HI: Aflatoxin B1exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiology Biomarkers & Prevention 2009; 18(3): 846–853.
35. Ponnudurai K, Vijayalakshmi R and Ilavarasan R: Standardization of Siddha herbal formulation – Vaasathi Kashayam according to PLIM guidelines. Int J Ayurveda Pharma Res 2024; 12(4): 56–63.Available from:https://ijapr.in/index.php/ijapr/article/view/3404
36. Bhattacharyya N and Kepnes LJ: Healthcare costs of acute and chronic tonsillar conditions in the pediatric population in the United States. Otolaryngol Head Neck Surg 2015; 152(4): 684–90. Available from:https://pubmed.ncbi.nlm.nih.gov/25912631
37. Deshpande S, Wanjari A, Tavhare SD & Patle A: Pharmaceutical standardisation and analytical validation of Herbal formulation capsule - UNEX. International Journal of Ayurvedic Medicine 2025; 15(4): 1072–1077. https://doi.org/10.47552/ijam.v15i4.5053
38. Siddiqui A and Hakim MA: Format for the Pharmacopeial Analytical Standards of Compound Formulation, Workshop on Standardization of Unani Drugs (Appendix), New Delhi; Central Council for Research in Unani Medicine 1995; 25.
39. Quality Standards of Indian Medicinal Plants. New Delhi: Indian Council of Medical Res 2003; 1: 10.
40. Jha P: Revalidating standard manufacturing procedures of Guduchi Ghana and Guduchi Satva and their comparative β-cell regeneration and glucose uptake activities in experimental animals. PG Dissertation, Discussion. Department of Rasa Shastra and Bhaishajya Kalpana AIIA, Delhi 2019.
41. Chhatre S, Nesari T and Somani G: Phytopharmacological overview of Tribulus terrestris. Pharmacogn Rev 2014; 8(15): 45-51.
42. Mishra S, Aeri V and Gaur PK: Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Biomed Res Int 2014; 808302.
43. The Ayurvedic Pharmacopoeia of India. 1st ed. Part I, Vol. I. New Delhi: Government of India, Ministry of Health and Family Welfare 2007; 51: 119.
44. Ngari WF: Investigation of selected pathogenic microorganisms and toxic elements in herbalmaterials used in management of oral health innairobi county, Kenya. Journal of Applied Environ Mental and Biological Sciences 2013; 3(12): 1–7.
45. Tavhare SD, Nishteswar K and Shukla VJ: Effect of seasonal variations on the phytoconstituents of Aśvagandhā w.r. to lunar cycles. Anc Sci Life 2016; 35(3): 150-8.
46. General guidelines for drug development of ayurvedic formulations. 1st ed. Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India, New Delhi, J. L. N. B. C. A. H. Anusandhan Bhavan, 61-65, Institutional Area, Opp. D-Block, Janakpuri, New Delhi - 110 058; 2018.
47. Tavhare SD and Nishteswar K: Collection Practices of Medicinal Plants - Vedic, Ayurvedic and Modern Perspectives. International Journal of Pharmaceutical & Biological Archives 2014; 5(5): 54 -61.
    

    ---

    How to cite this article:

    Ansari MA, Bijauliya RK, Kannojia P and Shankhdhar PK: Standardization of herbal capsule formulations: a review. Int J Pharmacognosy 2026; 13(4): 221-29. doi link: http://dx.doi.org/10.13040/IJPSR.0975-8232.IJP.13(4).221-29.

    ---

    This Journal licensed under a Creative Commons Attribution-Non-commercial-Share Alike 3.0 Unported License.